Back

Timing matters: clinical outcomes of early sodium-glucose cotransporter-2 inhibitor initiation in acute heart failure

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Cardiorenal interactions and early therapeutic signals in acute heart failure Pharmacotherapy Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Bernardo Lisboa Resende

Coimbra Hospital and University Center, Coimbra (Portugal)

5 More presentations in this session

Presentation thumbnail
Early empagliflozin initiation after hospitalization for heart failure in the United States: a target trial emulation
Professor S. Greene (Durham, US)
Abstract
Presentation thumbnail
Clinical efficacy of sotagliflozin for heart failure outcomes across cardiac biomarker levels in SCORED
Doctor R. Aggarwal (Boston, US)
Abstract
Presentation thumbnail
Efficacy and safety of finerenone in patients with cardio-kidney-metabolic syndrome and history of cancer: the FINE-HEART pooled analysis
Assistant Professor M. Ruppert (Boston, US)
Abstract
Presentation thumbnail
Not all creatinine rises are kidney injury, early renal congestion phenotypes in acute heart failure
Mrs E. Vice (Atlanta, US)
Abstract
Presentation thumbnail
Initiation of mineralocorticoid receptor antagonists in patients with cardiorenal diseases: potassium changes, hyperkalaemia risk and discontinuation in the CaRe study
Unknown S. Greene (Durham, US)
Abstract

Access the full session

Session thumbnail
Cardiorenal interactions and early therapeutic signals in acute heart failure

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026
You may be interested in
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios
thumbnail
Congress Presentation
Audience Q&A
thumbnail
Congress Presentation
Did we forget ARNI in the era of SGLTi?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources